USANA Health Sciences Inc. (USNA) PT Raised to $135 at Pivotal Research Amid 'Blow-Out' Qtr

Go back to USANA Health Sciences Inc. (USNA) PT Raised to $135 at Pivotal Research Amid 'Blow-Out' Qtr

USANA Health Sciences (USNA) Tops Q2 EPS by 23c, Revenues Beat; Boosts FY18 EPS/Revenues Outlook

July 24, 2018 4:35 PM EDT

USANA Health Sciences (NYSE: USNA) reported Q2 EPS of $1.36, $0.23 better than the analyst estimate of $1.13. Revenue for the quarter came in at $301.5 million versus the consensus estimate of $284.54 million.

Our operating results for the second quarter exceeded our expectations and reflect the momentum we are seeing in most of our regions. This momentum helped us generate the highest quarterly revenue and earnings per share in the Companys history, said Kevin Guest, Chief Executive Officer. Although the... More